Skip to content

Watch for malnutrition risk in children with HIV after starting ART

Expanded access to ART has the potential to avert millions of AIDS orphans in Africa

Nevirapine for breastfeeding infants: benefit of 6-week course still evident after one year

Adverse effects of ART use in pregnancy: prematurity continues to raise concerns

Optimising infant HIV treatment in resource-limited settings: when can nevirapine be used?

Six months of nevirapine prophylaxis for breastfeeding infants reduces transmission by 76% if mother not on ART

Anaemia more likely in infants exposed to maternal ARVs during pregnancy and breastfeeding

No reduction in postnatal death or illness with cotrimoxazole prophylaxis for mothers with HIV

NNRTIS and PIs equal in children, trials shows, but PIs may delay need for switch to second-line